Nine Chapters Capital Management LLC Invests $530,000 in Phibro Animal Health Corporation (PAHC)

Nine Chapters Capital Management LLC acquired a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 14,300 shares of the company’s stock, valued at approximately $530,000. Phibro Animal Health Corporation accounts for approximately 1.2% of Nine Chapters Capital Management LLC’s investment portfolio, making the stock its 23rd largest position. Nine Chapters Capital Management LLC owned approximately 0.07% of Phibro Animal Health Corporation at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of PAHC. Victory Capital Management Inc. boosted its position in shares of Phibro Animal Health Corporation by 79.2% during the 1st quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after purchasing an additional 2,021 shares during the period. State of Alaska Department of Revenue boosted its position in shares of Phibro Animal Health Corporation by 80.9% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock worth $136,000 after purchasing an additional 1,650 shares during the period. Municipal Employees Retirement System of Michigan boosted its position in shares of Phibro Animal Health Corporation by 3.6% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after purchasing an additional 150 shares during the period. KBC Group NV purchased a new position in shares of Phibro Animal Health Corporation during the 2nd quarter worth approximately $166,000. Finally, Capital Fund Management S.A. purchased a new position in shares of Phibro Animal Health Corporation during the 2nd quarter worth approximately $210,000. 49.74% of the stock is owned by hedge funds and other institutional investors.

In other Phibro Animal Health Corporation news, VP Daniel M. Bendheim sold 1,443 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $40.05, for a total transaction of $57,792.15. Following the completion of the sale, the vice president now directly owns 300 shares in the company, valued at $12,015. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Richard G. Johnson sold 55,529 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $36.30, for a total transaction of $2,015,702.70. Following the sale, the chief financial officer now owns 15,900 shares of the company’s stock, valued at $577,170. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 292,448 shares of company stock valued at $10,624,994. 51.88% of the stock is owned by insiders.

A number of equities analysts recently weighed in on PAHC shares. Credit Suisse Group increased their price objective on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research report on Thursday, August 31st. Piper Jaffray Companies reissued a “buy” rating and issued a $41.00 price target (down previously from $42.00) on shares of Phibro Animal Health Corporation in a research report on Thursday, August 31st. BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 23rd. Bank of America Corporation reissued an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Finally, Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $41.00 price target for the company in a research report on Tuesday. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $34.60.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The company had revenue of $194.84 million during the quarter, compared to the consensus estimate of $192.47 million. During the same period in the previous year, the firm earned $0.32 earnings per share. Phibro Animal Health Corporation’s revenue for the quarter was up 3.0% on a year-over-year basis.

TRADEMARK VIOLATION NOTICE: This article was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.com-unik.info/2017/11/02/nine-chapters-capital-management-llc-invests-530000-in-phibro-animal-health-corporation-pahc.html.

Phibro Animal Health Corporation Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

What are top analysts saying about Phibro Animal Health Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Phibro Animal Health Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit